Joel Greenblatt Moderna, Inc. Transaction History

Gotham Asset Management, LLC

$6.49 Billion
Q1 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Moderna, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 71,810 shares of MRNA stock, worth $8.53 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

71,810

Previous 66,102 8.64%

Holding current value

$8.53 Million

Previous $6.57 Million 16.42%

% of portfolio

0.12%

Previous 0.12%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $487,291 - $658,931	5,708 Added 8.64%	71,810 $7.65 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $2.73 Million - $4.09 Million	39,210 Added 145.81%	66,102 $6.57 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $1.14 Million - $1.5 Million	-11,837 Reduced 30.56%	26,892 $2.78 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $4.5 Million - $6.1 Million	-37,978 Reduced 49.51%	38,729 $4.71 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $520,256 - $755,571	-3,835 Reduced 4.76%	76,707 $11.8 Million

Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $5.38 Million - $9.54 Million	-45,440 Reduced 36.07%	80,542 $14.5 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $6.04 Million - $9.93 Million	51,126 Added 68.3%	125,982 $14.9 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $62,313 - $93,945	532 Added 0.72%	74,856 $10.7 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $5.79 Million - $10.8 Million	45,753 Added 160.14%	74,324 $12.8 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $4.08 Million - $6.66 Million	18,075 Added 172.21%	28,571 $7.26 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $2.33 Million - $5.08 Million	10,496 New	10,496 $4.04 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $237,605 - $429,778	-1,829 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $432,571 - $736,852	-3,962 Reduced 68.42%	1,829 $240,000
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $8,020 - $20,722	-122 Reduced 2.06%	5,791 $605,000
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $13,367 - $23,333	-246 Reduced 3.99%	5,913 $418,000
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $44,386 - $119,680	-1,496 Reduced 19.54%	6,159 $395,000
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $136,105 - $241,744	7,655 New	7,655 $229,000

Others Institutions Holding MRNA

# of Institutions

1,036

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account